News | September 14, 2021

DICE Therapeutics Announces Pricing of Upsized Initial Public Offering SOUTH SAN FRANCISCO, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) — DICE Therapeutics, Inc. (Nasdaq: DICE), a biopharmaceutical company leveraging its proprietary technology platform to build a...

News | September 9, 2021

PDS Biotech Completes Enrollment of Lead-In Safety Cohort in VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer FLORHAM PARK, N.J., Sept. 09, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq:...

News | August 30, 2021

Kit Check Hires New Chief Technology Officer WASHINGTON, August 30 – Kit Check today announced the addition of Vijay Venkatesh as Chief Technology Officer. Mr. Venkatesh brings vast expertise leading technology teams that have used new data sets and business models to...

News | August 5, 2021

TigerConnect Announces Expanded Product Suite to Revolutionize Clinical Collaboration and Cut Care CostsIntuitive Communication Capabilities Designed Around and For Today’s Healthcare Worker SANTA MONICA, Calif. — August 5, 2021 — TigerConnect, healthcare’s most...

News | July 2, 2021

Rallybio Announces Clinical Proof of Concept for RLYB211, an Anti-HPA-1a Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) — Data to be Presented at the International Society on Thrombosis and Haemostasis (ISTH) 2021 Virtual...

News | July 28, 2021

Rallybio Corporation Announces Pricing of Initial Public Offering NEW HAVEN, Conn.–(BUSINESS WIRE)–Jul. 28, 2021– Rallybio Corporation (Rallybio), a clinical-stage biotechnology company committed to identifying and accelerating the development of...